“Global Non-Invasive Prenatal Testing (NIPT) Market By Application (Trisomy, Microdeletion Syndrome, Other Applications), By Method (Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests) and Region- Global Market Size, Status and Forecast to 2026″, published by Verified Market Research.


The global Non-Invasive Prenatal Testing (NIPT) Market size is projected to grow from USD 3,340.2 Million in 2018 to USD 9,234.5 Million by 2026, at a CAGR of 13.85% from 2019 to 2026. High risk of chromosomal abnormalities with increasing maternal age is expected to support market growth during the forecast period.



Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=11053&utm_source=Free&utm_medium=004#downlaod-report



Browse in-depth TOC on “Global Non-Invasive Prenatal Testing (NIPT) Market”

54 – Tables
39 – Figures
87 – Pages



In terms of Application, the Trisomy segment is estimated to be the fastest-growing type in the Global Non-Invasive Prenatal Testing (NIPT) market in 2019.



By Method, the market is classified into Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests. Global Non-Invasive Prenatal Testing (NIPT) Market for Ultrasound Detection segment is expected to be largest during the forecast period. Ultrasound imaging (Ultrasonography) is used as a routine part of prenatal care in the first and/or second trimesters for detecting chromosome aneuploidies and other birth defects. Although due to the major drawbacks of this method, it is being replaced by many other effective methods, it still has the highest penetration in the market, it being a traditional used method.


In addition to this, growing preference for non-invasive techniques over invasive methods is likely to create enormous opportunities for the market growth. Non-invasive or minimally invasive methods such NIPT increases the potential for women to test of genetic mutations. With non-invasive or minimally invasive methods in general, there are several advantages as compared to its counterpart as it involves overall patient safety. Non-invasive or minimally invasive methods also have higher customer satisfaction rates though decreasing or eliminating the overall patient recovery time.

 
 Get More Information @ – https://www.verifiedmarketresearch.com/download-sample/?rid=11053&utm_source=Free&utm_medium=004#downlaod-report



North America dominated the Global Non-Invasive Prenatal Testing (NIPT) Market in 2018. U.S. accounted for the largest market share of the North America market in 2018.



However, Asia-Pacific an anticipated to grow at the highest CAGR during the forecast period owing to several factors, such as the high prevalence of genetic disorders distributed in huge population base, rising consumer preferences for non-invasive techniques over invasive ones, growing awareness about genetic abnormalities and leaps in technological advancements. Japan, India, Malaysia, and China are few of the major developers and sellers of NIPTs.

Key players



Natera, Inc., Beijing Genomics Institute, Illumina, Inc., Laboratory Corporation of America Holdings, F. Hoffman-La Roche Ltd., Yourgene Health, Perkinelmer, Inc., and Agilent Technologies, Inc. are the key players operating in the Global Non-Invasive Prenatal Testing (NIPT) market. Acquisitions and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Global Non-Invasive Prenatal Testing (NIPT) Market.



Obtain Report Details @ https://www.verifiedmarketresearch.com/press-release/non-invasive-prenatal-testing-nipt-market/?utm_source=Free&utm_medium=004